Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial.

M Boogaerts; DJ Winston; EJ Bow; G Garber; AC Reboli; AP Schwarer; N Novitzky; A Boehme; E Chwetzoff; K De Beule; Itraconazole Neutropenia Study Group; Werner Linkesch

doi:10.7326/0003-4819-135-6-200109180-00010

Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial.

M Boogaerts
, DJ Winston
, EJ Bow
, G Garber
, AC Reboli
, AP Schwarer
, N Novitzky
, A Boehme
, E Chwetzoff
, K De Beule
, Itraconazole Neutropenia Study Group
, Werner Linkesch (Collaborator)

Division of Haematology

Research output: Contribution to journal › Research article

235 Citations (Web of Science)

Original language	English
Journal	Annals of Internal Medicine
DOIs	https://doi.org/10.7326/0003-4819-135-6-200109180-00010
Publication status	Published - 2001

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Branches of science

302 Clinical Medicine

DOI

10.7326/0003-4819-135-6-200109180-00010

Links

Cite this

Boogaerts, M., Winston, DJ., Bow, EJ., Garber, G., Reboli, AC., Schwarer, AP., Novitzky, N., Boehme, A., Chwetzoff, E., De Beule, K., Itraconazole Neutropenia Study Group, & Linkesch, W. (2001). Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-135-6-200109180-00010

@article{ccd5944124034a348d9b32febd54141e,

title = "Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial.",

author = "M Boogaerts and DJ Winston and EJ Bow and G Garber and AC Reboli and AP Schwarer and N Novitzky and A Boehme and E Chwetzoff and \{De Beule\}, K and \{Itraconazole Neutropenia Study Group\} and Werner Linkesch",

year = "2001",

doi = "10.7326/0003-4819-135-6-200109180-00010",

language = "English",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

}

Boogaerts, M, Winston, DJ, Bow, EJ, Garber, G, Reboli, AC, Schwarer, AP, Novitzky, N, Boehme, A, Chwetzoff, E, De Beule, K, Itraconazole Neutropenia Study Group & Linkesch, W 2001, 'Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial.', Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-135-6-200109180-00010

Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial. / Boogaerts, M; Winston, DJ; Bow, EJ et al.
In: Annals of Internal Medicine, 2001.

Research output: Contribution to journal › Research article

TY - JOUR

T1 - Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial.

AU - Boogaerts, M

AU - Winston, DJ

AU - Bow, EJ

AU - Garber, G

AU - Reboli, AC

AU - Schwarer, AP

AU - Novitzky, N

AU - Boehme, A

AU - Chwetzoff, E

AU - De Beule, K

AU - Itraconazole Neutropenia Study Group

A2 - Linkesch, Werner

PY - 2001

Y1 - 2001

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000170972500003

UR - https://pubmed.ncbi.nlm.nih.gov/11560454

U2 - 10.7326/0003-4819-135-6-200109180-00010

DO - 10.7326/0003-4819-135-6-200109180-00010

M3 - Research article

C2 - 11560454

SN - 0003-4819

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

ER -

Boogaerts M, Winston DJ, Bow EJ, Garber G, Reboli AC, Schwarer AP et al. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial. Annals of Internal Medicine. 2001. doi: 10.7326/0003-4819-135-6-200109180-00010